Autres langues Themis Medicare Limited NSE India S.E.

Actions

THEMISMED

INE083B01024

Marché Fermé - NSE India S.E. Autres places de cotation 13:43:56 28/06/2024			Varia. 5j.	Varia. 1 janv.
209,7 ^INR	-0,03 %		-4,53 %	-1,88 %

14/05	Themis Medicare Limited annonce ses résultats pour l'exercice clos le 31 mars 2024	CI
14/05	Themis Medicare Limited annonce ses résultats pour le quatrième trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Themis Medicare Limited Recommends Dividend for Financial Year Ended March 31, 2024, Payable on or after July 22, 2024	14/05
Themis Medicare Limited Reports Earnings Results for the Full Year Ended March 31, 2024	14/05
Themis Medicare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	14/05
Themis Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	10/02
Themis Medicare Limited Launches REMITHEM	10/11
Themis Medicare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	04/11
Themis Medicare Limited Announces Incorporation of Wholly Owned Subsidiary	20/09/23
Themis Medicare Limited Announces Cessation of Vijay Agarwal as Independent Director	09/09/23
Themis Medicare Limited Appoints Reena Patel as Alternate Non-Executive Non- Non-Independent Director to Dr. Adam Demeter, Effective September 11, 2023	07/09/23
Themis Medicare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/08/23
Themis Medicare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	13/05/23
Themis Medicare Limited Reports Earnings Results for the Full Year Ended March 31, 2023	13/05/23
Themis Medicare Limited Recommends Dividend for Financial Year Ended 31 March 2023	13/05/23
Themis Medicare Limited Announces Board Resignations	02/05/23
Themis Medicare Gets Drug Controller General of India’s No-Objection for Diclofenac Injection	17/02/23
Themis Medicare Announces DCGI Approval of Remifentanil Hydrochloride 1mg/2mg for Injection for Import and Marketing	17/02/23
Themis Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	03/02/23
Themis Medicare Launches Drug for Treatment of Menopausal Symptoms in India	04/01/23
Themis Medicare Ltd. Launches Lenzetto Â¡Global Brand of Estradiol Novel Drug Delivery System	03/01/23
Themis Medicare Posts Decline in Fiscal Q2 Consolidated Profit	09/11/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Themis Medicare Limited NSE India S.E.

Actions

THEMISMED

INE083B01024

Autres langues

Filtres